Clinical trials: VZV
Herpes Zoster (HZ), Shingles
A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 40 Years and Older
This phase 2 study in China will evaluate the immunogenicity and safety of the Recombinant Zoster Vaccine, LYB004 in adults aged 40 years and older.
- Conditions
- Herpes Zoster (HZ), Shingles, VZV, Recombinant Zoster Vaccine
- Trial name
- NCT07311148
- Testing
- Low dose antigen and low dose adjuvant of LYB004, Low dose antigen and high dose adjuvant of LYB004, High dose antigen and low dose adjuvant of LYB004
- Where
- China
- Volunteers
- 840 people, healthy volunteers welcome
- Sponsor
- Guangzhou Patronus Biotech Co., Ltd.
VZV, Varicella Immunisation
Study on Booster Immunization With Varicella Vaccine at Different Intervals
The goal of this clinical trial is to evaluate the immunogenicity and safety of booster immunization of varicella live attenuated vaccine (varicella vaccine hereafter) at different intervals.
- Trial name
- NCT06994052
- Testing
- Varicella vaccine
- Where
- China
- Volunteers
- 412 people, healthy volunteers welcome
- Sponsor
- Sinovac (Dalian) Vaccine Technology Co., Ltd.